stockrowHUTCHMED (China) Limited Sponsored ADR (HCM) vs Prestige Consumer Healthcare Inc. (PBH)
- HUTCHMED (China) Limited Sponsored ADR HCM 14.93 +5.14%
- Prestige Consumer Healthcare Inc. PBH 43.20 −2.53%
HUTCHMED (China) Limited Sponsored ADR and Prestige Consumer Healthcare Inc. are both Drug Manufacturers Specialty & Generic companies. HUTCHMED (China) Limited Sponsored ADR is the larger, with a market value of $2.5B against $2.1B — 1.2× the size. HUTCHMED (China) Limited Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Prestige Consumer Healthcare Inc. trades at 13.7×. HUTCHMED (China) Limited Sponsored ADR grew revenue faster over the last twelve months: 245.2% against 5.10%. Prestige Consumer Healthcare Inc. has the higher net margin (13.3% vs −23.6%) and the higher return on invested capital (9.59% vs 0.00%). Across the 18 metrics below, Prestige Consumer Healthcare Inc. leads on 12 and HUTCHMED (China) Limited Sponsored ADR on 6.
Valuation
Profitability
| Metric | HCM | PBH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 44.40% | 52.47% | 53.51% |
| Operating margin | 0.00% | 24.95% | 0.00% |
| Net margin | (23.63%) | 13.29% | (2.45%) |
| Free cash flow margin | 0.00% | 18.35% | 0.00% |
| Return on equity | 0.00% | 8.23% | (0.80%) |
| Return on assets | 0.00% | 3.80% | (1.67%) |
| Return on invested capital | 0.00% | 9.59% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack